Advik Laboratories Ltd — Updates, 30-05-2025: Company Update

MPS Pharmaa Limited has submitted its Annual Secretarial Compliance Report confirming adherence to applicable SEBI regulations, with exceptions limited to delayed payment of Annual Listing Fees to BSE for multiple years. Due to these defaults, the company's shares have been suspended on BSE but continue to trade on a restricted, trade-for-trade basis once weekly. The company cites fund shortages for non-payment and is actively seeking opportunities and funds to resume normal operations and clear dues. No director disqualifications or significant regulatory actions have been reported, and the company remains focused on improving its financial position and restarting business activity.